These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30153634)

  • 1. Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression.
    Wilkinson ST; Kiselycznyk C; Banasr M; Webler RD; Haile C; Mathew SJ
    J Affect Disord; 2018 Dec; 241():514-518. PubMed ID: 30153634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women.
    Meyer JD; Koltyn KF; Stegner AJ; Kim JS; Cook DB
    Psychoneuroendocrinology; 2016 Dec; 74():286-294. PubMed ID: 27697714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
    Duncan WC; Sarasso S; Ferrarelli F; Selter J; Riedner BA; Hejazi NS; Yuan P; Brutsche N; Manji HK; Tononi G; Zarate CA
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):301-11. PubMed ID: 22676966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
    Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
    J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.
    Sanacora G; Kendell SF; Levin Y; Simen AA; Fenton LR; Coric V; Krystal JH
    Biol Psychiatry; 2007 Mar; 61(6):822-5. PubMed ID: 17141740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
    Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML
    J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
    Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
    J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole likely lacks antidepressant efficacy in ketamine non-responders.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():197-9. PubMed ID: 25139008
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
    Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
    World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A; Marazziti D; Catena M; Domenici L; Del Debbio A; Bianchi C; Mannari C; Martini C; Da Pozzo E; Schiavi E; Mariotti A; Roncaglia I; Palla A; Consoli G; Giovannini L; Massimetti G; Dell'Osso L
    J Affect Disord; 2008 Jan; 105(1-3):279-83. PubMed ID: 17553570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
    Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
    J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.